These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1469094)
21. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Howarth DJ; Samson D; Stirling Y; Seghatchian MJ Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307 [TBL] [Abstract][Full Text] [Related]
22. Antithrombin and heparin. Carrell R; Skinner R; Warden M; Whisstock J Mol Med Today; 1995 Aug; 1(5):226-31. PubMed ID: 17607884 [TBL] [Abstract][Full Text] [Related]
23. Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method. Corral J; Rivera J; Martínez C; González-Conejero R; Miñano A; Vicente V J Lab Clin Med; 2003 Nov; 142(5):298-305. PubMed ID: 14647033 [TBL] [Abstract][Full Text] [Related]
24. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509 [TBL] [Abstract][Full Text] [Related]
25. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide. Mille B; Watton J; Barrowcliffe TW; Mani JC; Lane DA J Biol Chem; 1994 Nov; 269(47):29435-43. PubMed ID: 7961924 [TBL] [Abstract][Full Text] [Related]
26. Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin. Meagher JL; Olson ST; Gettins PG J Biol Chem; 2000 Jan; 275(4):2698-704. PubMed ID: 10644732 [TBL] [Abstract][Full Text] [Related]
27. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391 [TBL] [Abstract][Full Text] [Related]
28. [Homozygous antithrombin type HBS deficiency; a family study]. Guermazi S; Elloumi-ZghaL H; Ben Hassine L; Romani S; Khalfallah N; Abdelhak S; Dellagi K Pathol Biol (Paris); 2007 Jun; 55(5):256-61. PubMed ID: 17140748 [TBL] [Abstract][Full Text] [Related]
29. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp). Bruce D; Perry DJ; Borg JY; Carrell RW; Wardell MR J Clin Invest; 1994 Dec; 94(6):2265-74. PubMed ID: 7989582 [TBL] [Abstract][Full Text] [Related]
30. Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis. Lane DA; Erdjument H; Flynn A; Di Marzo V; Panico M; Morris HR; Greaves M; Dolan G; Preston FE Br J Haematol; 1989 Jan; 71(1):91-6. PubMed ID: 2917133 [TBL] [Abstract][Full Text] [Related]
31. Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding. Borg JY; Brennan SO; Carrell RW; George P; Perry DJ; Shaw J FEBS Lett; 1990 Jun; 266(1-2):163-6. PubMed ID: 2365065 [TBL] [Abstract][Full Text] [Related]
32. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576 [TBL] [Abstract][Full Text] [Related]
33. Inherited thrombotic tendency in a pedigree with antithrombin La Rochelle (N405K) and factor V Leiden. Hayden PJ; O'Brien M; Collins B; O'Farrelly C; Murphy K Clin Lab Haematol; 2003 Jun; 25(3):191-3. PubMed ID: 12755798 [TBL] [Abstract][Full Text] [Related]
34. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590 [TBL] [Abstract][Full Text] [Related]
35. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin. Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821 [TBL] [Abstract][Full Text] [Related]
36. Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants. Hultin MB; McKay J; Abildgaard U Thromb Haemost; 1988 Jun; 59(3):468-73. PubMed ID: 3055413 [TBL] [Abstract][Full Text] [Related]
37. Expression and functional characterization of two natural heparin-binding site variants of antithrombin. Dinarvand P; Yang L; Villoutreix BO; Rezaie AR J Thromb Haemost; 2018 Feb; 16(2):330-341. PubMed ID: 29215785 [TBL] [Abstract][Full Text] [Related]
38. Familial overexpression of beta antithrombin caused by an Asn135Thr substitution. Bayston TA; Tripodi A; Mannucci PM; Thompson E; Ireland H; Fitches AC; Hananeia L; Olds RJ; Lane DA Blood; 1999 Jun; 93(12):4242-7. PubMed ID: 10361121 [TBL] [Abstract][Full Text] [Related]
39. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III. Watton J; Longstaff C; Lane DA; Barrowcliffe TW Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518 [TBL] [Abstract][Full Text] [Related]
40. Insight into residues critical for antithrombin function from analysis of an expanded database of sequences that includes frog, turtle, and ostrich antithrombins. Backovic M; Gettins PG J Proteome Res; 2002; 1(4):367-73. PubMed ID: 12645893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]